Bimekizumab Efficacy in High-Impact Areas: Pooled 2-Year Analysis in Scalp, Nail, and Palmoplantar Psoriasis from Phase 3/3b Randomized Controlled Trials by Merola, Joseph F., Gottlieb, Alice B., Pinter, Andreas, Elewski, Boni, Gooderham, Melinda, Warren, Richard B., Piaserico, Stefano, Wixted, Krista, Cross, Nancy, Tilt, Nicola, Wiegratz, Susanne, Mrowietz, Ulrich

Get full text

Long-Term Durability of Certolizumab Pegol in Patients with Rheumatoid Arthritis Over 5 Years: An Analysis of Pooled Clinical Trial Data by Bykerk, Vivian P., Nash, Peter, Nicholls, David, Tanaka, Yoshiya, Winthrop, Kevin, Popova, Christina, Tilt, Nicola, Haaland, Derek

Get full text

Long-Term Health-Related Quality of Life in Patients with Plaque Psoriasis Treated with Certolizumab Pegol: Three-Year Results from Two Randomised Phase 3 Studies (CIMPASI-1 and CI... by Gisondi, Paolo, Gottlieb, Alice B., Elewski, Boni, Augustin, Matthias, McBride, Sandy, Tsai, Tsen-Fang, de la Loge, Christine, Fierens, Frederik, López Pinto, José M., Tilt, Nicola, Lebwohl, Mark

Get full text

Publisher Correction: Long-Term Health-Related Quality of Life in Patients with Plaque Psoriasis Treated with Certolizumab Pegol: Three-Year Results from Two Randomised Phase 3 Stu... by Gisondi, Paolo, Gottlieb, Alice B., Elewski, Boni, Augustin, Matthias, McBride, Sandy, Tsai, Tsen-Fang, de la Loge, Christine, Fierens, Frederik, López Pinto, José M., Tilt, Nicola, Lebwohl, Mark

Get full text

Associations Between Safety of Certolizumab Pegol, Disease Activity, and Patient Characteristics, Including Corticosteroid Use and Body Mass Index by Bykerk, Vivian P., Blauvelt, Andrew, Curtis, Jeffrey R., Gaujoux‐Viala, Cécile, Kvien, Tore K., Winthrop, Kevin, Tilt, Nicola, Popova, Christina, Mariette, Xavier, Haraoui, Boulos

Get full text

52668 Bimekizumab efficacy and safety in Japanese patients with generalized pustular psoriasis and erythrodermic psoriasis: 3-year results from BE BRIGHT, a multicenter, open-label... by Okubo, Yukari, Tada, Yayoi, Takahashi, Hidetoshi, Abe, Masatoshi, Yamanaka, Keiichi, Tilt, Nicola, Cross, Nancy, Deherder, Delphine, Matano, Mizuho, Nakagawa, Hidemi

Get full text

52675 Bimekizumab efficacy across subgroups of patients with moderate to severe plaque psoriasis: Pooled analysis from up to 3 years of treatment in 5 phase 3/3b clinical trials by Strober, Bruce, Krueger, James G., Magnolo, Nina, Vender, Ronald, Boehncke, Wolf-Henning, Hong, H. Chih-ho, Tilt, Nicola, Staelens, Fabienne, Wiegratz, Susanne, Paul, Carle

Get full text

43878 Bimekizumab versus secukinumab for the treatment of nail psoriasis in patients with moderate to severe plaque psoriasis: Results from the BE RADIANT phase 3b trial by Eyerich, Kilian, Gottlieb, Alice B., Piaserico, Stefano, Beissert, Stefan, Gooderham, Melinda, Kirby, Brian, Tilt, Nicola, Madden, Cynthia, Wiegratz, Susanne, de Cuyper, Dirk, Elewski, Boni

Get full text

33259 Improvements in anxiety and depression among patients with moderate to severe plaque psoriasis treated with certolizumab pegol: Three-year results from 2 phase 3 trials (CIMP... by Armstrong, April, McBride, Sandra, Spelman, Lynda, Fernández-Peñas, Pablo, Rich, Phoebe, Martin, George, Tilt, Nicola, Lopez Pinto, Jose M., Popova, Christina, Hellot, Scarlett

Get full text

Patient Satisfaction with CIMZIA® (Certolizumab Pegol) AutoClicks® in the UK by Bailey, Kathryn, Mountian, Irina, Bruggraber, Richard, Sunderland, Kerri, Tilt, Nicola, Szegvari, Boglarka

Get full text

Impact of high rheumatoid factor levels on treatment outcomes with certolizumab pegol and adalimumab in patients with rheumatoid arthritis by Smolen, Josef S, Taylor, Peter C, Tanaka, Yoshiya, Takeuchi, Tsutomu, Hashimoto, Motomu, Cara, Carlos, Lauwerys, Bernard, Tilt, Nicola, Ufuktepe, Baran, Xavier, Ricardo M, Balsa, Alejandro, Curtis, Jeffrey R, Mikuls, Ted R, Weinblatt, Michael

Get full text

Efficacy and Safety of Certolizumab Pegol in Japanese Patients with Moderate to Severe Plaque Psoriasis: 52-Week Results by Umezawa, Yoshinori, Asahina, Akihiko, Imafuku, Shinichi, Tada, Yayoi, Sano, Shigetoshi, Morita, Akimichi, Sakurai, Shinya, Hoshii, Naoki, Tilt, Nicola, Nakagawa, Hidemi

Get full text

Bimekizumab 3-year Efficacy in High-Impact Areas in Moderate to Severe Plaque Psoriasis: Pooled Results from Five Phase 3/3b Trials by Merola, Joseph F., Conrad, Curdin, Hampton, Philip, Lambert, Jo, Gottlieb, Alice B., Tilt, Nicola, Cross, Nancy, Wiegratz, Susanne, Gooderham, Melinda

Get full text

Bimekizumab cumulative clinical benefit in patients with moderate to severe hidradenitis suppurativa through 1 year of the BE HEARD I&II phase 3 trials by Garg, Amit, Armstrong, April, Sofen, Howard, Martorell-Calatayud, Antonio, Podda, Maurizio, Nomura, Toshifumi, Wiegratz, Susanne, Lambert, Jérémy, Rolleri, Robert, Tilt, Nicola, Zouboulis, Christos C

Get full text

Bimekizumab impact on draining tunnels: A dynamic assessment in patients with moderate to severe HS using pooled Week 48 results from BE HEARD I&II by Tzellos, Thrasyvoulos, Hsiao, Jennifer, Porter, Martina, Benhadou, Farida, Bechara, Falk G., Gooderham, Melinda, Takahashi, Hidetoshi, Zouboulis, Christos C, Pansar, Ingrid, Rolleri, Robert, Tilt, Nicola, Sayed, Christopher

Get full text

Efficacy of certolizumab pegol across baseline rheumatoid factor subgroups in patients with rheumatoid arthritis: Post‐hoc analysis of clinical trials by Tanaka, Yoshiya, Takeuchi, Tsutomu, Haaland, Derek, Hall, Stephen, Inanc, Nevsun, Li, Zhanguo, Xavier, Ricardo M., Cara, Carlos, Tilt, Nicola, Taylor, Peter C.

Get full text

Bimekizumab Effect on the Need for Concomitant Rescue Interventions by HiSCR Response Level in Patients with Moderate to Severe Hidradenitis Suppurativa from BE HEARD I&II by Bechara, Falk G., Forman, Seth, Garg, Amit, Guillem, Philippe, Van der Zee, Hesel H., Giamarellos-Bourboulis, Evangelos J., Morita, Akimichi, Lukowski, Bartosz, Rolleri, Robert, Dokhe, Pratiksha, Tilt, Nicola, Hamzavi, Iltefat

Get full text

Evaluation of the efficacy of systemic danofloxacin in the treatment of induced acute Escherichia coli bovine mastitis by Poutrel, Bernard, Stegemann, Michael R, Roy, Olivier, Pothier, Francis, Tilt, Nicola, Payne-Johnson, Mark

Get full text

Molnupiravir versus placebo in unvaccinated and vaccinated patients with early SARS-CoV-2 infection in the UK (AGILE CST-2): a randomised, placebo-controlled, double-blind, phase 2... by Khoo, Saye H, FitzGerald, Richard, Saunders, Geoffrey, Middleton, Calley, Ahmad, Shazaad, Edwards, Christopher J, Hadjiyiannakis, Dennis, Walker, Lauren, Lyon, Rebecca, Shaw, Victoria, Mozgunov, Pavel, Periselneris, Jimstan, Woods, Christie, Bullock, Katie, Hale, Colin, Reynolds, Helen, Downs, Nichola, Ewings, Sean, Buadi, Amanda, Cameron, David, Edwards, Thomas, Knox, Emma, Donovan-Banfield, I'ah, Greenhalf, William, Chiong, Justin, Lavelle-Langham, Lara, Jacobs, Michael, Northey, Josh, Painter, Wendy, Holman, Wayne, Lalloo, David G, Tetlow, Michelle, Hiscox, Julian A, Jaki, Thomas, Fletcher, Thomas, Griffiths, Gareth, Paton, Nicholas, Hayden, Fred, Darbyshire, Janet, Lucas, Amy, Lorch, Ulrika, Freedman, Andrew, Knight, Richard, Julious, Stevan, Byrne, Rachel, Cubas Atienzar, Ana, Jones, Jayne, Williams, Chris, Song, Anna, Dixon, Jan, Alexandersson, Anja, Hatchard, Parys, Tilt, Emma, Titman, Andrew, Doce Carracedo, Ale, Chandran Gorner, Vatsi, Davies, Andrea, Woodhouse, Louis, Carlucci, Nicola, Okenyi, Emmanuel, Bula, Marcin, Dodd, Kate, Gibney, Jennifer, Dry, Lesley, Rashid Gardner, Zalina, Sammour, Amin, Cole, Christine, Rowland, Tim, Tsakiroglu, Maria, Yip, Vincent, Osanlou, Rostam, Stewart, Anna, Parker, Ben, Turgut, Tolga, Ahmed, Afshan, Starkey, Kay, Subin, Sujamole, Stockdale, Jennifer, Herring, Lisa, Baker, Jonathon, Oliver, Abigail, Pacurar, Mihaela, Owens, Dan, Munro, Alistair, Babbage, Gavin, Faust, Saul, Harvey, Matthew, Pratt, Danny, Nagra, Deepak, Vyas, Aashish

Get full text